BCL-005

DB17242ExperimentalVaccines

BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells.

Also known as
BCL-005 (fused (hybrid) melanoma-dendritic cells)
Code names
BCL-005

Which companies are running trials of BCL-005, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In